Raymond James Boosts Boston Scientific (NYSE:BSX) Price Target to $122.00
Boston Scientific (NYSE:BSX – Get Free Report) had its price objective lifted by equities research analysts at Raymond James ...
Boston Scientific Co. (NYSE:BSX) Given Consensus Recommendation of “Buy” by Brokerages
Boston Scientific Co. (NYSE:BSX – Get Free Report) has been given an average recommendation of “Buy” by the twenty-three ...
WHDH16d
Boston City Council set to vote on resolution about continuing White Stadium demolition
BOSTON (WHDH) - The Boston City Council is set to vote on a resolution about how to move forward with the demolition of White Stadium. Some councilors are asking for an immediate pause on the ...
Nasdaq24d
Boston Scientific Corporation Common Stock (BSX) P/E & PEG Ratios
Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...
American College of Cardiology24d
FDA Update: Early Device Replacement, Recall of Boston Scientific Accolade Pacemakers
The U.S. Food and Drug Administration (FDA) has issued a safety communication noting the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices.
Business Insider28d
Boston Scientific (BSX) Gets a Buy from TD Cowen
In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $110.00. The company’s shares closed ...